Dr Jitesh Neupane discusses his hematoids model and opportunities to study childhood blood disorders and future stem cell therapies.

Add Yahoo as a preferred source to see more of our stories on Google. CXCL12 may help scientists mass-produce artificial red blood cells by triggering key steps in their development. (CREDIT: ...

"By perfecting stem cell methods that mimic the development of the normal blood stem cells found in our bodies we can understand and develop personalized treatments for a range of blood diseases, ...

Co-corresponding authors Jian Xu,PhD, (left) and Min Ni, PhD, (right) and co-first authors Junhua Lyu, PhD, (center left) and Yuannyu Zhang, PhD, (center right) identified and characterized a ...

The production of red blood cells from stem cells has emerged as a transformative approach to address chronic blood shortages and meet the increasing demand for transfusion therapies. By harnessing ...

The amino acid glutamine plays an unexpected role in erythropoiesis, the differentiation of erythroid progenitor cells into mature red blood cells. Ordinarily, glutamine is broken down by stem cells ...

Europe produced 58.8 million tonnes of plastics in 2022. — © AFP JOSH EDELSON Europe produced 58.8 million tonnes of plastics in 2022. — © AFP JOSH EDELSON ...

If CXCR4 is removed from the cells, red blood cell development stops at subsequent stages, and bone marrow production drops severely. That loss helps to confirm just how important the CXCL12-CXCR4 ...

In their quest for safe, mass-producible artificial blood, geneticists have long struggled. Our limited knowledge of genetic pathways that govern the development of blood has kept us from producing ...